Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-49,141
Closed -$1.17M – 840
2024
Q4
$1.17M Buy
49,141
+32
+0.1% +$893 0.1% 302
2024
Q3
$1.38M Sell
49,109
-53,164
-52% -$1.5M 0.12% 300
2024
Q2
$2.67M Buy
102,273
+14,151
+16% +$294K 0.25% 134
2024
Q1
$1.93M Buy
88,122
+42,824
+95% +$918K 0.18% 200
2023
Q4
$1.05M Sell
45,298
-6,892
-13% -$139K 0.12% 278
2023
Q3
$1.03M Sell
52,190
-6
-0% -$118 0.13% 277
2023
Q2
$1.18M Sell
52,196
-15
-0% -$302 0.16% 208
2023
Q1
$1.03M Buy
+52,211
New +$1M 0.14% 252

Other funds holding RXO

PDT Partners's RXO Position: Q1 2025 in Review

PDT Partners sold out of RXO (RXO) in Q1 2025, closing a stake of 49,141 shares — an estimated $1.17M sold.

PDT Partners first reported a position in RXO in Q1 2023 and held it in 8 quarters. The position peaked at $2.67M in Q2 2024. 258 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

  • PDT Partners reported no remaining RXO position as of Q1 2025 after selling out during the quarter.
  • PDT Partners sold 49,141 RXO shares in Q1 2025, an estimated $1.17M.
  • PDT Partners first reported a position in RXO in Q1 2023 and held it in 8 quarters.
  • PDT Partners's RXO position peaked at $2.67M in Q2 2024.
  • 258 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.